List of Tables
Table 1. Global Urinary Tract Infection Medications Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Urinary Tract Infection Medications Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Urinary Tract Infection Medications Market Competitive Situation by Manufacturers in 2025
Table 4. Global Urinary Tract Infection Medications Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Urinary Tract Infection Medications Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Urinary Tract Infection Medications Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Urinary Tract Infection Medications Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Urinary Tract Infection Medications Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Urinary Tract Infection Medications, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Urinary Tract Infection Medications, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Urinary Tract Infection Medications, Product Types and Applications
Table 12. Global Key Manufacturers of Urinary Tract Infection Medications, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Urinary Tract Infection Medications Companies by Tier (Tier 1, Tier 2, Tier 3), based on Urinary Tract Infection Medications Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Urinary Tract Infection Medications Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Urinary Tract Infection Medications Sales by Region (K Units), 2021–2026
Table 18. Global Urinary Tract Infection Medications Sales Market Share by Region (2021–2026)
Table 19. Global Urinary Tract Infection Medications Sales by Region (K Units), 2027–2032
Table 20. Global Urinary Tract Infection Medications Sales Market Share by Region (2027–2032)
Table 21. Global Urinary Tract Infection Medications Revenue by Region (US$ Million), 2021–2026
Table 22. Global Urinary Tract Infection Medications Revenue Market Share by Region (2021–2026)
Table 23. Global Urinary Tract Infection Medications Revenue by Region (US$ Million), 2027–2032
Table 24. Global Urinary Tract Infection Medications Revenue Market Share by Region (2027–2032)
Table 25. North America Urinary Tract Infection Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Urinary Tract Infection Medications Sales by Country (K Units), 2021–2026
Table 27. North America Urinary Tract Infection Medications Sales by Country (K Units), 2027–2032
Table 28. North America Urinary Tract Infection Medications Revenue by Country (US$ Million), 2021–2026
Table 29. North America Urinary Tract Infection Medications Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Urinary Tract Infection Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Urinary Tract Infection Medications Sales by Country (K Units), 2021–2026
Table 32. Europe Urinary Tract Infection Medications Sales by Country (K Units), 2027–2032
Table 33. Europe Urinary Tract Infection Medications Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Urinary Tract Infection Medications Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Urinary Tract Infection Medications Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Urinary Tract Infection Medications Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Urinary Tract Infection Medications Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Urinary Tract Infection Medications Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Urinary Tract Infection Medications Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Urinary Tract Infection Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Urinary Tract Infection Medications Sales by Country (K Units), 2021–2026
Table 42. Latin America Urinary Tract Infection Medications Sales by Country (K Units), 2027–2032
Table 43. Latin America Urinary Tract Infection Medications Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Urinary Tract Infection Medications Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Urinary Tract Infection Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Urinary Tract Infection Medications Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Urinary Tract Infection Medications Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Urinary Tract Infection Medications Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Urinary Tract Infection Medications Revenue by Country (US$ Million), 2027–2032
Table 50. Global Urinary Tract Infection Medications Sales (K Units) by Type (2021–2026)
Table 51. Global Urinary Tract Infection Medications Sales (K Units) by Type (2027–2032)
Table 52. Global Urinary Tract Infection Medications Sales Market Share by Type (2021–2026)
Table 53. Global Urinary Tract Infection Medications Sales Market Share by Type (2027–2032)
Table 54. Global Urinary Tract Infection Medications Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Urinary Tract Infection Medications Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Urinary Tract Infection Medications Revenue Market Share by Type (2021–2026)
Table 57. Global Urinary Tract Infection Medications Revenue Market Share by Type (2027–2032)
Table 58. Global Urinary Tract Infection Medications Price (US$/Unit) by Type (2021–2026)
Table 59. Global Urinary Tract Infection Medications Price (US$/Unit) by Type (2027–2032)
Table 60. Global Urinary Tract Infection Medications Sales (K Units) by Application (2021–2026)
Table 61. Global Urinary Tract Infection Medications Sales (K Units) by Application (2027–2032)
Table 62. Global Urinary Tract Infection Medications Sales Market Share by Application (2021–2026)
Table 63. Global Urinary Tract Infection Medications Sales Market Share by Application (2027–2032)
Table 64. Global Urinary Tract Infection Medications Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Urinary Tract Infection Medications Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Urinary Tract Infection Medications Revenue Market Share by Application (2021–2026)
Table 67. Global Urinary Tract Infection Medications Revenue Market Share by Application (2027–2032)
Table 68. Global Urinary Tract Infection Medications Price (US$/Unit) by Application (2021–2026)
Table 69. Global Urinary Tract Infection Medications Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Inc. Company Information
Table 71. Pfizer Inc. Description and Business Overview
Table 72. Pfizer Inc. Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Inc. Urinary Tract Infection Medications Product
Table 74. Pfizer Inc. Recent Developments/Updates
Table 75. Teva Pharmaceuticals Company Information
Table 76. Teva Pharmaceuticals Description and Business Overview
Table 77. Teva Pharmaceuticals Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Teva Pharmaceuticals Urinary Tract Infection Medications Product
Table 79. Teva Pharmaceuticals Recent Developments/Updates
Table 80. Novo Nordisk A/S Company Information
Table 81. Novo Nordisk A/S Description and Business Overview
Table 82. Novo Nordisk A/S Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Novo Nordisk A/S Urinary Tract Infection Medications Product
Table 84. Novo Nordisk A/S Recent Developments/Updates
Table 85. GlaxoSmithKline plc Company Information
Table 86. GlaxoSmithKline plc Description and Business Overview
Table 87. GlaxoSmithKline plc Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. GlaxoSmithKline plc Urinary Tract Infection Medications Product
Table 89. GlaxoSmithKline plc Recent Developments/Updates
Table 90. Bayer AG Company Information
Table 91. Bayer AG Description and Business Overview
Table 92. Bayer AG Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Bayer AG Urinary Tract Infection Medications Product
Table 94. Bayer AG Recent Developments/Updates
Table 95. Novartis Ag Company Information
Table 96. Novartis Ag Description and Business Overview
Table 97. Novartis Ag Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Novartis Ag Urinary Tract Infection Medications Product
Table 99. Novartis Ag Recent Developments/Updates
Table 100. Cipla Inc. Company Information
Table 101. Cipla Inc. Description and Business Overview
Table 102. Cipla Inc. Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Cipla Inc. Urinary Tract Infection Medications Product
Table 104. Cipla Inc. Recent Developments/Updates
Table 105. Merck & Co. Inc. Company Information
Table 106. Merck & Co. Inc. Description and Business Overview
Table 107. Merck & Co. Inc. Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Merck & Co. Inc. Urinary Tract Infection Medications Product
Table 109. Merck & Co. Inc. Recent Developments/Updates
Table 110. Eli Lily Company Company Information
Table 111. Eli Lily Company Description and Business Overview
Table 112. Eli Lily Company Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Eli Lily Company Urinary Tract Infection Medications Product
Table 114. Eli Lily Company Recent Developments/Updates
Table 115. Utility Therapeutics Company Information
Table 116. Utility Therapeutics Description and Business Overview
Table 117. Utility Therapeutics Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Utility Therapeutics Urinary Tract Infection Medications Product
Table 119. Utility Therapeutics Recent Developments/Updates
Table 120. Allecra Therapeutic Company Information
Table 121. Allecra Therapeutic Description and Business Overview
Table 122. Allecra Therapeutic Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Allecra Therapeutic Urinary Tract Infection Medications Product
Table 124. Allecra Therapeutic Recent Developments/Updates
Table 125. MEDICE Company Information
Table 126. MEDICE Description and Business Overview
Table 127. MEDICE Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. MEDICE Urinary Tract Infection Medications Product
Table 129. MEDICE Recent Developments/Updates
Table 130. Northeast Pharmaceuticals Company Information
Table 131. Northeast Pharmaceuticals Description and Business Overview
Table 132. Northeast Pharmaceuticals Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Northeast Pharmaceuticals Urinary Tract Infection Medications Product
Table 134. Northeast Pharmaceuticals Recent Developments/Updates
Table 135. Whiteson Pharma Company Information
Table 136. Whiteson Pharma Description and Business Overview
Table 137. Whiteson Pharma Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Whiteson Pharma Urinary Tract Infection Medications Product
Table 139. Whiteson Pharma Recent Developments/Updates
Table 140. Guangxi Qingzhipin Pharmaceutical Co., Ltd. Company Information
Table 141. Guangxi Qingzhipin Pharmaceutical Co., Ltd. Description and Business Overview
Table 142. Guangxi Qingzhipin Pharmaceutical Co., Ltd. Urinary Tract Infection Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Guangxi Qingzhipin Pharmaceutical Co., Ltd. Urinary Tract Infection Medications Product
Table 144. Guangxi Qingzhipin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Urinary Tract Infection Medications Distributors List
Table 148. Urinary Tract Infection Medications Customers List
Table 149. Urinary Tract Infection Medications Market Trends
Table 150. Urinary Tract Infection Medications Market Drivers
Table 151. Urinary Tract Infection Medications Market Challenges
Table 152. Urinary Tract Infection Medications Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Urinary Tract Infection Medications
Figure 2. Global Urinary Tract Infection Medications Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Urinary Tract Infection Medications Market Share by Type: 2025 & 2032
Figure 4. Quinolones Product Picture
Figure 5. Cephalosporins Product Picture
Figure 6. Penicillins Product Picture
Figure 7. Sulfonamides Product Picture
Figure 8. Furans Product Picture
Figure 9. Others Product Picture
Figure 10. Global Urinary Tract Infection Medications Market Value by Application (US$ Million), 2021–2032
Figure 11. Global Urinary Tract Infection Medications Market Share by Application: 2025 & 2032
Figure 12. Online Pharmacy
Figure 13. Hospital
Figure 14. Clinic
Figure 15. Others
Figure 16. Global Urinary Tract Infection Medications Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Urinary Tract Infection Medications Market Size (US$ Million), 2021–2032
Figure 18. Global Urinary Tract Infection Medications Sales (K Units), 2021–2032
Figure 19. Global Urinary Tract Infection Medications Average Price (US$/Unit), 2021–2032
Figure 20. Urinary Tract Infection Medications Report Years Considered
Figure 21. Urinary Tract Infection Medications Sales Share by Manufacturers in 2025
Figure 22. Global Urinary Tract Infection Medications Revenue Share by Manufacturers in 2025
Figure 23. Top 5 and Top 10 Global Urinary Tract Infection Medications Players: Market Share by Revenue in Urinary Tract Infection Medications in 2025
Figure 24. Urinary Tract Infection Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 25. Global Urinary Tract Infection Medications Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 26. North America Urinary Tract Infection Medications Sales Market Share by Country (2021–2032)
Figure 27. North America Urinary Tract Infection Medications Revenue Market Share by Country (2021–2032)
Figure 28. United States Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Canada Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Europe Urinary Tract Infection Medications Sales Market Share by Country (2021–2032)
Figure 31. Europe Urinary Tract Infection Medications Revenue Market Share by Country (2021–2032)
Figure 32. Germany Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. France Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. U.K. Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Italy Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Russia Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Asia Pacific Urinary Tract Infection Medications Sales Market Share by Region (2021–2032)
Figure 38. Asia Pacific Urinary Tract Infection Medications Revenue Market Share by Region (2021–2032)
Figure 39. China Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Japan Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. South Korea Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. India Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Australia Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. China Taiwan Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Southeast Asia Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Latin America Urinary Tract Infection Medications Sales Market Share by Country (2021–2032)
Figure 47. Latin America Urinary Tract Infection Medications Revenue Market Share by Country (2021–2032)
Figure 48. Mexico Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Brazil Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Argentina Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Colombia Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Middle East and Africa Urinary Tract Infection Medications Sales Market Share by Country (2021–2032)
Figure 53. Middle East and Africa Urinary Tract Infection Medications Revenue Market Share by Country (2021–2032)
Figure 54. Turkey Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Saudi Arabia Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. UAE Urinary Tract Infection Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Global Sales Market Share of Urinary Tract Infection Medications by Type (2021–2032)
Figure 58. Global Revenue Market Share of Urinary Tract Infection Medications by Type (2021–2032)
Figure 59. Global Urinary Tract Infection Medications Price (US$/Unit) by Type (2021–2032)
Figure 60. Global Sales Market Share of Urinary Tract Infection Medications by Application (2021–2032)
Figure 61. Global Revenue Market Share of Urinary Tract Infection Medications by Application (2021–2032)
Figure 62. Global Urinary Tract Infection Medications Price (US$/Unit) by Application (2021–2032)
Figure 63. Urinary Tract Infection Medications Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
